These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Intralesional cidofovir as adjuvant for the successful management of aggressive respiratory papillomatosis in an infant. Durvasula VS, Richter GT. Int J Pediatr Otorhinolaryngol; 2013 Nov; 77(11):1912-5. PubMed ID: 24063771 [Abstract] [Full Text] [Related]
8. Cidofovir: to use or not to use? Soma MA, Albert DM. Curr Opin Otolaryngol Head Neck Surg; 2008 Feb; 16(1):86-90. PubMed ID: 18197029 [Abstract] [Full Text] [Related]
13. Response to Dikkers letter to the editor regarding "systematic review of intralesional cidofovir dosing regimens in the treatment of recurrent respiratory papillomatosis". Clamp PJ, Saunders MW. Int J Pediatr Otorhinolaryngol; 2013 Oct; 77(10):1789. PubMed ID: 24021212 [No Abstract] [Full Text] [Related]
14. Stepped-dose protocol of cidofovir therapy in recurrent respiratory papillomatosis in children. Akst LM, Lee W, Discolo C, Knott D, Younes A, Koltai PJ. Arch Otolaryngol Head Neck Surg; 2003 Aug; 129(8):841-6. PubMed ID: 12925342 [Abstract] [Full Text] [Related]
16. Potential risk factors associated with the use of cidofovir to treat benign human papillomavirus-related disease. Donne AJ, Hampson L, He XT, Day PJ, Salway F, Rothera MP, Homer JJ, Hampson IN. Antivir Ther; 2009 Aug; 14(7):939-52. PubMed ID: 19918098 [Abstract] [Full Text] [Related]
17. Serial office-based intralesional injection of cidofovir in adult-onset recurrent respiratory papillomatosis. Co J, Woo P. Ann Otol Rhinol Laryngol; 2004 Nov; 113(11):859-62. PubMed ID: 15562893 [Abstract] [Full Text] [Related]
20. Cidofovir for the treatment of recurrent respiratory papillomatosis: a review of the literature. Shehab N, Sweet BV, Hogikyan ND. Pharmacotherapy; 2005 Jul; 25(7):977-89. PubMed ID: 16006276 [Abstract] [Full Text] [Related] Page: [Next] [New Search]